Acknowledgments
Cancer, Thomas
LUNG, MARION, ROSENTHAL, BLOOD, HEART, CANCER
A multidisciplinary, independent Data and Safety Monitoring Board (DSMB) appointed by the National Heart, Lung, and Blood Institute (NHLBI) monitors the quality of the data and protects the safety of patients enrolled in the HAPIN trial. NHLBI DSMB: Catherine Karr (Chair), Nancy R Cook, Stephen Hecht, Joseph Millum, Nalini Sathiakumar, Paul K Whelton, Gail G Weinmann and Thomas Croxton (Executive Secretaries). Program Coordination: Gail Rodgers, Bill & Melinda Gates Foundation; Claudia L. Thompson, National Institute of Environmental Health Science; Mark J. Parascandola, National Cancer Institute; Marion Koso-Thomas, Eunice Kennedy Shriver National Institute of Child Health and Human Development; Joshua P Rosenthal, Fogarty International Center; Conception R Nierras, NIH Office of Strategic Coordination Common Fund; Katherine Kavounis, Dong-Yun Kim, Antonello Punturieri, and Barry S Schmetter, NHLBI. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the US National Institutes of Health or Department of Health and Human Services.